Kalaris Therapeutics, Inc 10-Q for FY2025 Q1
Kalaris Therapeutics, Inc. (KLRS)
10-Q
2025-05-14
For: 2025-03-31
View Original
Added on
April 08, 2026
About this 10-Q
Kalaris Therapeutics, Inc filed this 10-Q on May 14, 2025, covering the quarter ended March 31, 2025 (FY2025 Q1).
Headline figures
Quarter ended March 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $10.2M
- compared with a net loss of $3.41M a year earlier
- Diluted EPS
- -$2.52
- compared with -$2.60 a year earlier